The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 15, 2021
Filed:
Jan. 23, 2018
Applicant:
Glaxosmithkline Intellectual Property Development Limited, Brentford, GB;
Inventors:
Feng Ren, Shanghai, CN;
Yingxia Sang, Shanghai, CN;
Weiqiang Xing, Shanghai, CN;
Yang Zhan, Shanghai, CN;
Baowei Zhao, Shanghai, CN;
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, Brentford, GB;
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 407/14 (2006.01); C07D 413/14 (2006.01); C07D 487/10 (2006.01); C07D 491/048 (2006.01); C07D 498/04 (2006.01); C07D 498/10 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 25/14 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61P 25/16 (2018.01); C07D 407/14 (2013.01); C07D 413/14 (2013.01); C07D 487/10 (2013.01); C07D 491/048 (2013.01); C07D 498/04 (2013.01); C07D 498/10 (2013.01);
Abstract
Compounds of Formula (I) or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising these compounds, the use of these compounds and compositions in the treatment of diseases in which LRRK-2 kinase is involved.